Miinalainen IJ: Difference between revisions
From Bioblast
Marte Verena (talk | contribs) No edit summary |
Marte Verena (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
|lastname=Miinalainen | |lastname=Miinalainen | ||
|firstname=Ilkka | |firstname=Ilkka | ||
| | |title=Ph.D. | ||
|institution=Biocenter Oulu Electron Microscopy Core Facility | |||
University of Oulu | |||
|address=Aapistie 5A, | |||
Β | |area code=90220 | ||
|city=Oulu | |||
|country=Finland | |||
|weblink=www. oulu.fi/biocenter/em | |||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} |
Revision as of 14:10, 20 June 2013
Name | Miinalainen Ilkka, Ph.D. |
---|---|
Institution | Biocenter Oulu Electron Microscopy Core Facility
University of Oulu |
Address | Aapistie 5A,, 90220 |
City | Oulu |
State/Province | |
Country | Finland |
[email protected] | |
Weblink | www. oulu.fi/biocenter/em |
O2k-Network Lab | IE Dublin Miinalainen I |
Labels:
Publications
Published | Reference | |
---|---|---|
Raesaenen 2016 Proc Natl Acad Sci U S A | 2016 | RΓ€sΓ€nen M, Degerman J, Nissinen TA, Miinalainen I, KerkelΓ€ R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, KivelΓ€ R, Alitalo K (2016) VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci U S A 113:13144-49. |